Plus Therapeutics Inc (PSTV) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.32
• Market Cap: $53.73M
• EPS: $-0.96
• 52-Week High: $2.31
• 52-Week Low: $0.16

Market Sentiment

Plus Therapeutics Inc currently has a Bullish sentiment score of 0.56.

About Plus Therapeutics Inc

Plus Therapeutics, Inc. is an innovative clinical-stage pharmaceutical company based in Austin, Texas, specializing in the development of advanced cancer therapies and treatments for serious diseases. The company is at the forefront of creating proprietary drug delivery technologies designed to enhance therapeutic efficacy in oncology. With a strong pipeline of promising drug candidates, Plus Therapeutics is strategically positioned to deliver novel therapeutic options that address substantia...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Plus Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PSTV pay dividends?

Plus Therapeutics Inc (PSTV) does not currently pay a regular dividend.

What is PSTV's market cap?

Plus Therapeutics Inc (PSTV) has a market capitalization of $53.73M with a current stock price of $0.32.